))
19. A New Era For Psychedelic Medicine | Professor David Nutt
Manage episode 294342202 series 2936276
Content provided by Fascinate Productions. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fascinate Productions or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Professor David Nutt is a neuropsychopharmacologist who has spent his career making the argument for a rational, evidence-based approach to drug policy and drug use. Since 2019 he’s also headed up the Centre for Psychedelic Research at Imperial College London alongside Dr. Robin Carhart-Harris. This episode explores the latest research in the field of psychedelics as well as the historical war on drugs and the ongoing challenges that come with studying psychedelics.
In this episode we discuss:
- Why psychedelic research is so important
- The War on Drugs as one of the worst examples of censorship of research in the history of science
- How current drug policy that does not reflect the truth about the majority of illegal drugs
- The societal impact of poorly informed drug policy
- The therapeutic potential for a range of psychedelics
- Psilocybin for the treatment of depression and end of life anxiety
- LSD, MDMA and ayahuasca (DMT)
- How psychedelics can expand our understanding of consciousness itself
- The evidence for microdosing
- Medicinal cannabis
- The detrimental impact of alcohol on health
- And so much more…
I’d love to hear how this episode lands with you. Please get in touch to let me know your thoughts @holistichealingproject.
Find out more about Drug Science: www.drugscience.com
Connect with Professor David Nutt on Twitter @ProfDavidNutt
and on The Drug Science Podcast.
Professor Nutt is Director of the Neuropsychopharmacology Unit at Imperial College London, President of the European College of Neuropsychopharmacology, and Chair of the Independent Scientific Committee on Drugs. He is also the current Edmund J Safra Professor of Neuropsychopharmacology at Imperial College London.
A Fascinate Productions podcast
22 episodes
Share
